Drug recall D-0559-2023

Class II Terminated reported May 10, 2023

Product

Glimepiride USP, 4 mg, 90 count-bottles, Rx only, Intas Pharm. Limited Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127, NDC 43063-0587-90

Reason for recall

CGMP deviations.

Lots and codes

Lots: A22B45 Exp. 01/31/24; C22A73, E22E41, C22D28, F22B68, G22A29, H22B97, K22A36 Exp. 03/31/24; K22B99, A23D07, B23B25 Exp. 10/31/24; B23B55 Exp. 06/30/25

Recall details

Recalling firm
PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK
Quantity
186 bottles
Distribution
Nationwide in the US.
Type
Voluntary: Firm initiated
Recall initiated
April 6, 2023
Terminated
April 30, 2024